{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T08:53:45Z","timestamp":1781427225414,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Increased radiosensitivity can cause adverse radiotherapy effects. Heterozygote variants in breast cancer risk genes increase cancer risk and may affect radiosensitivity. This study assessed their impact on individual radiosensitivity to determine the radiation risk for gene carriers. Radiosensitivity was analyzed in 273 patients with breast cancer risk gene variants. Using fluorescence in situ hybridization (FiSH), chromosomal aberrations were quantified as breaks per metaphase (B\/M) after ex vivo irradiation of blood lymphocytes. Results were compared with healthy controls and breast cancer cases, both without confirmed non-carrier status, limiting gene-specific conclusions. Gene carriers showed slightly increased radiosensitivity (mean 0.488 B\/M\u2009\u00b1\u20090.134) compared with healthy controls (0.411 B\/M\u2009\u00b1\u20090.088;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) but similar to breast cancer control group (0.498 B\/M\u2009\u00b1\u20090.192;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.563). In\n                    <jats:italic>BRCA1\/2<\/jats:italic>\n                    carriers, radiosensitivity was slightly increased, while single cases in\n                    <jats:italic>BARD1<\/jats:italic>\n                    ,\n                    <jats:italic>RAD51<\/jats:italic>\n                    , and\n                    <jats:italic>MSH<\/jats:italic>\n                    variants suggested a possible increase (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.003). Radiosensitivity was influenced by gene locus, variant type, age, and cancer history. 24.5% of carriers exceeded a cutoff of \u2265\u20090.55 B\/M, where dose reduction could be considered. Radiosensitivity of breast cancer risk gene carriers varies and is slightly increased. Individuals with increased radiosensitivity risk should consider testing.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-57275-x","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T08:03:37Z","timestamp":1781424217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer risk genes affecting individual radiosensitivity"],"prefix":"10.1038","volume":"16","author":[{"given":"Ramona K. G.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara Zuhair","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ga\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Woltereck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin C.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-3226","authenticated-orcid":false,"given":"Luitpold","family":"Distel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas C. F.","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"issue":"5","key":"57275_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"C Breast Cancer Association","year":"2021","unstructured":"Breast Cancer Association, C. et al. Breast cancer risk genes - association analysis in more than 113,000 Women. N Engl. J. Med. 384 (5), 428\u2013439 (2021).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"57275_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu, C. et al. A Population-based study of genes previously implicated in breast cancer. N Engl. J. Med. 384 (5), 440\u2013451 (2021).","journal-title":"N Engl. J. Med."},{"key":"57275_CR3","doi-asserted-by":"publisher","first-page":"747318","DOI":"10.1155\/2013\/747318","volume":"2013","author":"P Apostolou","year":"2013","unstructured":"Apostolou, P. & Fostira, F. Hereditary breast cancer: the era of new susceptibility genes. Biomed. Res. Int. 2013, 747318 (2013).","journal-title":"Biomed. Res. Int."},{"issue":"10","key":"57275_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study G","year":"2000","unstructured":"Anglian Breast Cancer Study G. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br. J. Cancer. 83 (10), 1301\u20131308 (2000).","journal-title":"Br. J. Cancer"},{"issue":"5","key":"57275_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1056\/NEJMe2035083","volume":"384","author":"SA Narod","year":"2021","unstructured":"Narod, S. A. Which genes for hereditary breast cancer? N Engl. J. Med. 384 (5), 471\u2013473 (2021).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"57275_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00066-024-02362-z","volume":"201","author":"A Van der Vorst","year":"2025","unstructured":"Van der Vorst, A. et al. Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention. Strahlenther Onkol. 201 (4), 368\u2013382 (2025).","journal-title":"Strahlenther Onkol"},{"key":"57275_CR7","doi-asserted-by":"crossref","unstructured":"Yoshimura, A., Imoto, I. & Iwata, H. Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. Int. J. Mol. Sci. 23(13). (2022).","DOI":"10.3390\/ijms23137481"},{"key":"57275_CR8","volume-title":"S3 Guideline Breast Cancer: Early Detection, Diagnosis, Therapy, and Follow-up Care Version 4.4","author":"L Onkologie","year":"2021","unstructured":"Onkologie, L. S3 Guideline Breast Cancer: Early Detection, Diagnosis, Therapy, and Follow-up Care Version 4.4 (German Guideline Program in Oncology (GGPO), 2021)."},{"issue":"1","key":"57275_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4143\/crt.2020.1247","volume":"54","author":"KH Kim","year":"2022","unstructured":"Kim, K. H. et al. Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1\/2 Mutations. Cancer Res. Treat. 54 (1), 54\u201364 (2022).","journal-title":"Cancer Res. Treat."},{"issue":"5","key":"57275_CR10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","volume":"74","author":"JM Pollard","year":"2009","unstructured":"Pollard, J. M. & Gatti, R. A. Clinical radiation sensitivity with DNA repair disorders: an overview. Int. J. Radiat. Oncol. Biol. Phys. 74 (5), 1323\u20131331 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"57275_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2003.10.001","volume":"69","author":"U Hoeller","year":"2003","unstructured":"Hoeller, U. et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol. 69 (2), 137\u2013144 (2003).","journal-title":"Radiother Oncol."},{"issue":"8","key":"57275_CR12","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.3390\/cimb45080418","volume":"45","author":"T Zuhair Kassem","year":"2023","unstructured":"Zuhair Kassem, T. et al. Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2. Curr. Issues Mol. Biol. 45 (8), 6618\u20136633 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"57275_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12877-018-0799-y","volume":"18","author":"B Schuster","year":"2018","unstructured":"Schuster, B. et al. Rate of individuals with clearly increased radiosensitivity rise with age both in healthy individuals and in cancer patients. BMC Geriatr. 18 (1), 105 (2018).","journal-title":"BMC Geriatr."},{"issue":"1","key":"57275_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2478\/raon-2013-0061","volume":"48","author":"J Auer","year":"2014","unstructured":"Auer, J. et al. Individual radiosensitivity in a breast cancer collective is changed with the patients\u2019 age. Radiol. Oncol. 48 (1), 80\u201386 (2014).","journal-title":"Radiol. Oncol."},{"issue":"1","key":"57275_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12883-020-01966-z","volume":"20","author":"J Stritzelberger","year":"2020","unstructured":"Stritzelberger, J. et al. Ex vivo radiosensitivity is increased in non-cancer patients taking valproate. BMC Neurol. 20 (1), 390 (2020).","journal-title":"BMC Neurol."},{"issue":"1","key":"57275_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12672-024-01395-1","volume":"15","author":"L Kuhlmann","year":"2024","unstructured":"Kuhlmann, L., Stritzelberger, J., Fietkau, R., Distel, L. V. & Hamer, H. M. Radiosensitivity in individuals with tuberous sclerosis complex. Discov Oncol. 15 (1), 525 (2024).","journal-title":"Discov Oncol."},{"issue":"5","key":"57275_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00066-004-1200-y","volume":"180","author":"U Keller","year":"2004","unstructured":"Keller, U. et al. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity. Strahlenther Onkol. 180 (5), 289\u2013296 (2004).","journal-title":"Strahlenther Onkol"},{"key":"57275_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-540-70581-9_21","volume-title":"Fluorescence In Situ Hybridization (FISH) \u2014 Application Guide","author":"L Distel","year":"2009","unstructured":"Distel, L., Keller, U., Neubauer, S. & Three-Color, FISH for the Detection of Individual Radiosensitivity. In Fluorescence In Situ Hybridization (FISH) \u2014 Application Guide (ed. Liehr, T.) 231\u2013241 (Springer Berlin Heidelberg, 2009)."},{"issue":"1","key":"57275_CR19","first-page":"345","volume":"307","author":"JR Savage","year":"1994","unstructured":"Savage, J. R. & Simpson, P. On the scoring of FISH-painted chromosome-type exchange aberrations. Mutat. Res. 307 (1), 345\u2013353 (1994).","journal-title":"Mutat. Res."},{"issue":"10","key":"57275_CR20","first-page":"581","volume":"171","author":"J Dunst","year":"1995","unstructured":"Dunst, J., Gebhart, E. & Neubauer, S. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?]. Strahlenther Onkol. 171 (10), 581\u2013586 (1995).","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"57275_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.radonc.2015.07.002","volume":"116","author":"K Ulrike","year":"2015","unstructured":"Ulrike, K. et al. NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients. Radiother Oncol 116(2), 323\u201330 (2015).","journal-title":"Radiother Oncol"},{"issue":"1","key":"57275_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2307\/3579194","volume":"145","author":"E Gebhart","year":"1996","unstructured":"Gebhart, E., Neubauer, S., Schmitt, G., Birkenhake, S. & Dunst, J. Use of a three-color chromosome in situ suppression technique for the detection of past radiation exposure. Radiat Res 145(1), 47\u201352 (1996).","journal-title":"Radiat Res"},{"issue":"3","key":"57275_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1667\/0033-7587(2002)157[0312:ROATAN]2.0.CO;2","volume":"157","author":"S Neubauer","year":"2002","unstructured":"Neubauer, S. et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat. Res. 157 (3), 312\u2013321 (2002).","journal-title":"Radiat. Res."},{"issue":"1","key":"57275_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cancergencyto.2004.05.018","volume":"157","author":"U Keller","year":"2005","unstructured":"Keller, U. et al. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genet Cytogenet 157(1), 25\u201332 (2005).","journal-title":"Cancer Genet Cytogenet"},{"key":"57275_CR25","doi-asserted-by":"publisher","DOI":"10.5936\/csbj.201204005","author":"SL Clark","year":"2012","unstructured":"Clark, S. L., Rodriguez, A. M., Snyder, R. R., Hankins, G. D. & Boehning, D. Structure-function of the tumor suppressor BRCA1. Comput Struct Biotechnol J https:\/\/doi.org\/10.5936\/csbj.201204005 (2012).","journal-title":"Comput Struct Biotechnol J"},{"key":"57275_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071034","author":"PR Andreassen","year":"2021","unstructured":"Andreassen, P. R., Seo, J., Wiek, C. & Hanenberg, H. Understanding BRCA2 function as a tumor suppressor based on domain-specific activities in DNA damage responses. Genes (Basel) https:\/\/doi.org\/10.3390\/genes12071034 (2021).","journal-title":"Genes (Basel)"},{"key":"57275_CR27","doi-asserted-by":"crossref","unstructured":"Schenker, H. et al. Increased sensitivity to ionizing radiation in a relevant subset of patients with cancer and systemic lupus erythematosus. Cells 14(8). (2025).","DOI":"10.3390\/cells14080569"},{"issue":"22","key":"57275_CR28","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2016.71.9260","volume":"35","author":"CR Espenschied","year":"2017","unstructured":"Espenschied, C. R. et al. Multigene panel testing provides a new perspective on Lynch syndrome. J Clin Oncol 35(22), 2568\u201375 (2017).","journal-title":"J Clin Oncol"},{"key":"57275_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rpd\/ncl495","volume":"122","author":"P Jeggo","year":"2006","unstructured":"Jeggo, P. & Lobrich, M. Radiation-induced DNA damage responses. Radiat Prot Dosimetry 122, 124\u20137 (2006).","journal-title":"Radiat Prot Dosimetry"},{"key":"57275_CR30","doi-asserted-by":"crossref","unstructured":"Ismail, T. et al. BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer. Pharmaceuticals (Basel) 17(3). (2024).","DOI":"10.3390\/ph17030333"},{"issue":"12","key":"57275_CR31","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00439-022-02462-9","volume":"141","author":"JD Peake","year":"2022","unstructured":"Peake, J. D. & Noguchi, E. Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair. Hum. Genet. 141 (12), 1811\u20131836 (2022).","journal-title":"Hum. Genet."},{"issue":"1","key":"57275_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jds.2025.09.010","volume":"21","author":"C Lou","year":"2026","unstructured":"Lou, C., Zhu, Y., Shi, L. & Liu, W. Systematic evaluation of genetic polymorphisms in carcinogen metabolizing enzymes associated with the risk of oral potentially malignant disorders occurrence. J. Dent. Sci. 21 (1), 604\u2013609 (2026).","journal-title":"J. Dent. Sci."},{"issue":"4","key":"57275_CR33","first-page":"249","volume":"6","author":"C Bolognesi","year":"1997","unstructured":"Bolognesi, C. et al. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 6 (4), 249\u2013256 (1997).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"57275_CR34","doi-asserted-by":"crossref","unstructured":"Brion, T. et al. Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial. Radiother Oncol.\u00a0110849. (2025).","DOI":"10.1016\/j.radonc.2025.110849"},{"issue":"1","key":"57275_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41598-025-85342-2","volume":"15","author":"P Burkon","year":"2025","unstructured":"Burkon, P. et al. Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial. Sci. Rep. 15 (1), 1387 (2025).","journal-title":"Sci. Rep."},{"key":"57275_CR36","doi-asserted-by":"crossref","unstructured":"Linge, A. et al. Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer. Strahlenther Onkol (2025).","DOI":"10.1007\/s00066-025-02438-4"},{"issue":"8","key":"57275_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/14737140.2018.1489245","volume":"18","author":"A Gupta","year":"2018","unstructured":"Gupta, A., Ohri, N. & Haffty, B. G. Hypofractionated radiation treatment in the management of breast cancer. Expert Rev. Anticancer Ther. 18 (8), 793\u2013803 (2018).","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"57275_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.15537\/smj.2021.42.3.20210660","volume":"42","author":"AF Alfouzan","year":"2021","unstructured":"Alfouzan, A. F. Radiation therapy in head and neck cancer. Saudi Med. J. 42 (3), 247\u2013254 (2021).","journal-title":"Saudi Med. J."},{"key":"57275_CR39","doi-asserted-by":"crossref","unstructured":"Ott, O. J. et al. External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis. Cancers (Basel) ;14(14). (2022).","DOI":"10.3390\/cancers14143520"},{"issue":"9","key":"57275_CR40","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.cell.2024.03.006","volume":"187","author":"LR Kong","year":"2024","unstructured":"Kong, L. R. et al. A glycolytic metabolite bypasses \u201ctwo-hit\u201d tumor suppression by BRCA2. Cell 187(9), 2269\u201387 (2024).","journal-title":"Cell"},{"issue":"1","key":"57275_CR41","doi-asserted-by":"publisher","first-page":"168277","DOI":"10.1016\/j.jmb.2023.168277","volume":"436","author":"A Minello","year":"2024","unstructured":"Minello, A. & Carreira, A. BRCA1\/2 Haploinsufficiency: Exploring the Impact of Losing one Allele. J. Mol. Biol. 436 (1), 168277 (2024).","journal-title":"J. Mol. Biol."},{"key":"57275_CR42","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1038\/ncomms6496","volume":"5","author":"S Pathania","year":"2014","unstructured":"Pathania, S. et al. BRCA1 haploinsufficiency for replication stress suppression in primary cells. Nat. Commun. 5, 5496 (2014).","journal-title":"Nat. Commun."},{"issue":"6453","key":"57275_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aax3649","volume":"365","author":"S Boettcher","year":"6453","unstructured":"Boettcher, S. et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365(6453), 599\u2013604 (6453).","journal-title":"Science"},{"issue":"1","key":"57275_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/09553009214551821","volume":"62","author":"JN Lucas","year":"1992","unstructured":"Lucas, J. N. et al. Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation. Int. J. Radiat. Biol. 62(1), 53\u201363 (1992).","journal-title":"Int. J. Radiat. Biol."},{"issue":"1","key":"57275_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijrobp.2008.01.007","volume":"71","author":"K Borgmann","year":"2008","unstructured":"Borgmann, K. et al. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 71(1), 256\u201364 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"57275_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-717X-6-32","volume":"6","author":"R Huber","year":"2011","unstructured":"Huber, R. et al. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients\u2013a follow-up study. Radiat. Oncol. 6, 32, 32. (2011).","journal-title":"Radiat. Oncol."},{"key":"57275_CR47","unstructured":"Eierstockkrebs, D. K. F. B. Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer. (2022)."},{"issue":"1","key":"57275_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13014-023-02291-8","volume":"18","author":"D Rzepka","year":"2023","unstructured":"Rzepka, D. et al. Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases. Radiat. Oncol. 18 (1), 98 (2023).","journal-title":"Radiat. Oncol."},{"issue":"6","key":"57275_CR49","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/annonc\/mdv139","volume":"26","author":"M Hecht","year":"2015","unstructured":"Hecht, M. et al. Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients. Ann. Oncol. 26(6), 1238\u201344 (2015).","journal-title":"Ann. Oncol."},{"key":"57275_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010148","author":"B Schuster","year":"2021","unstructured":"Schuster, B. et al. Influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14010148 (2021).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"57275_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13014-019-1444-4","volume":"15","author":"T Mayo","year":"2019","unstructured":"Mayo, T. et al. Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? Radiat. Oncol. 15 (1), 2 (2019).","journal-title":"Radiat. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57275-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T08:10:39Z","timestamp":1781424639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57275-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57275"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57275-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics review committee of the Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU) (21_19 B). Written informed consent was obtained from all the patients. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"18377"}}